. Herbs used as insomnia aids in western countries Name
Traditional usage Mechanism Lemon balm (Melissa offi cinalis)
Remedy for sleep problems Inhibits the breakdown of the sedative neurotransmitter GABA and possibly acetylcholine (Awad et al., 2007; Yoo et al., 2011 
) Valerian (Valeriana offi cialis)
Remedy for sleep problems Increases the brain levels of GABAa (Trauner et al., 2008; Benke et al., 
2009) Hops (Humulus lupulus)
Beer brewing, sleep aid Slows down the breakdown of GABA and acts via the melatonin receptors (Awad et al., 2007) Passionfl ower (Passifl ora spp)
Treatment of anxiety
Action similar to benzodiazepine drugs (Carrasco et al., 2009) 
Kava kava (Piper methysticum)
Treat anxiety, sleep aid. Not well understood -affects the enzyme CYP2D6, vulnerable to liver damage from use of kava (banned in many countries) (Gurley et al., 2008 Common tea Action similar to the benzodiazepine drugs (Shinomiya et al., 2005) St. John's wort
(Hypericum perforatum)
Depression, insomnia Increases brain levels of GABA (Gobbi et al., 2001; Langosch et al., 2002) Jasmine (Jasminum spp)
Common tea Contains L-theanine, an amino acid which relieves anxiety and stress, but is not sedative by itself (Kuroda et al., 2005) . that have been found to promote wakefulness, including the serotonergic neurons of the dorsal raphe nucleus (DRN), noradrenergic cell groups in the locus coeruleus (LC), the histaminergic populations in the tuberomammillary nucleus (TMN) of the posterior hypothalamus (PH), and to additional regions of the hypothalamus (Sherin et al., 1998; Steininger et al., 1999; Takahashi et al., 2010) . The wake-promoting roles of the DRN, LC, PH, and TM cell groups as well as the PH have been demonstrated by many methods (Perez and Benedito, 1997; Shouse et al., 2000) SLEEP ARCHITECTURE
Most sleep-active neurons in all sites slowly discharge during waking. Increase in discharge anticipated EEG synchronization at sleep onset by a few seconds in each site. The sleep in most mammals is divided into two major types of sleep, rapid eye movement (REM) sleep and non-rapid eye movement (NREM) sleep (McCarley, 2007) . Humans usually fall asleep by entering NREM sleep, a phase accompanied by characteristic changes in the EEG. The next stage is REM sleep, which is characterized not only by REM but also by a complete inhibition of skeletal muscle tone. Before commencing on a description of sleep architecture, it is important to defi ne three terms used to characterize the EEG: frequency, amplitude, and morphology (Lanquart et al., 1996) . During NREM sleep neuronal activity is low, and metabolic rate and brain temperature are at their lowest. According to a simplifi ed model, the onset of NREM sleep is driven by VLPO area neurons that exert an inhibitory effect on TMN histaminergic neurons (Liu et al., 2010) . Consistent with this hypothesis is the fi nding that VLPO and TMN neurons exhibit opposite patterns of activity during the sleep-wake cycle (Hayaishi, 2000) . In contrast to the VLPO neurons, which are active during sleep, the TMN neurons are persistently active during wakefulness, reduce their fi ring during NREM sleep, and become inactive during REM sleep (Ramesh et al., 2004) .
In addition, sleep is staged by determining the predominant pattern in 10-30 second "epochs" of EEG, muscle, and eye movement activity. (Steinfels et al., 1980; Armitage, 1995) . For this reason, REM sleep has been called paradoxical sleep. One of the prime characteristics of REM sleep is a low level of muscle tone. In contrast to the diffuse brain structures involved in NREM sleep, the neuroanatomy of REM-active structures is relatively circumscribed. As previously mentioned, the primary oscillator that drives REM sleep appears to be located in the pontine tegmentum (PT). REM-on cholinergic neurons in the pedunculopontine tegmental (PPT) and laterodorsal tegmental (LDT) nuclei have high charge rates during wakefulness and REM sleep, and low discharge rates during NREM sleep. The norepinephrine and serotonin REM-off cells, which are excited by orexin neurons during wakefulness, start to wane in activity, which gradually release the cholinergic REM-on cells from their inhibitory effects (Gilbert and Lydic, 1994; Harris, 2005) .
INSOMNIA
Insomnia is a widespread health complaint, and is one of the most common sleeping disorders. Insomnia is defi ned as a condition of unsatisfactory quality and inadequate quantity of sleep; it is characterized by diffi culty initiating or maintaining sleep and early fi nal waking. Insomnia occurs in 30-50% of people over 60 years old (Avidan, 2005) . Gender differences exist as well, with older women being more likely to complain of insomnia than older men. The consequences of disturbed sleep are well known and may include diffi culty sustaining attention and slowed response time. These consequences can be more pronounced in older adults and may even be misinterpreted as symptoms of dementia and Alzheimer's disease (Wu et al., 2010) . Primary insomnia is sleeplessness that is not attributable to a medical, psychiatric, or environmental cause. The etiology of primary insomnia relates in part to psychological conditioning processes. Secondary insomnia is a symptom caused by medical, psychiatric, or environmental factors. According to the International Classifi cation of Sleep Disorders, persistent insomnia of more than 4 weeks duration is regarded as signifi cant insomnia (Bailes et al., 2009; Naude et al., 2010) . The causes of insomnia include psychiatric disorders; social disturbances; physical problems such as cardiopulmonary failure and chronic pain; drugs and foods such as caffeine, nicotine, alcohol, and amphetamines; as well as an irregular sleep-wake cycle. Approximately 35 percent of the adult population has insomnia during the course of a year. Up to seven percent indicate that insomnia is chronic, severe, or both 7-9. In contrast to the occasional sleepless night experienced by most people, insomnia may be a persistent or recurrent problem with serious complications, such as anxiety and depression (Doi et al., 2000; Eytan et al., 2011) .
The economic burden of insomnia is very high, with the largest proportion of all expenses (76%) attributed to insomnia-related work absences and reduced productivity. As the economic burden of untreated insomnia is much higher than that of treating insomnia, future clinical trials should evaluate the cost-benefi ts, cost-utility, and cost-effectiveness of insomnia therapies (Daley et al., 2009) . Effective treatments for insomnia include short and long acting benzodiazepines, although many of these are associated with adverse effects, daytime sedation (hangover) and dependence with continued use (Blatter et al., 1988) . More modern drugs such as zolpidem, zopiclone and zaleplon avoid some of the adverse effects of benzodiazepines by selective binding to receptor sites (Meier et al., 1988; Ohta, 1996) . Some individuals with insomnia or trouble sleeping use CAM therapies to treat their condition. In this review, we will demonstrate that widely available wake-promoting and sleep-promoting herbs, most of which have commonly been used in Europe and the USA. We also like to focus attention on some herbs that have traditionally been used to treat insomnia in oriental countries.
HERBS AS SLEEP AIDS
Diffi culties with daytime performance or unwanted sleepiness are often manifestations of sleep stage disruption or insuffi cient sleep. The majority of people seen in North American Sleep Disorder Centers presents with excessive daytime sleepiness. Conventional treatment for insomnia includes drugs that exert a depressant effect on the central nervous systems (CNS) and psychological therapy. Most of the drugs prescribed for insomnia involve some risk of overdose, tol- www.biomolther.org erance, habituation, and addiction (Cheng et al., 2010) . As alternative therapies, herbal products and other agents with sedative-hypnotic effects are increasingly sought after by the general population. These therapies are less likely to have the drawbacks of conventional drugs. How the effi cacy of alternative therapies compares to conventional therapies warrants further investigation. Over-the-counter sleep aids are becoming popular as an alternative to prescription hypnotics. Surveys of young adults indicate that approximately 10 percent used nonprescription medications in the past year to improve sleep. Patients reported self-medicating with herbs, hormones, and amino acids in an effort to improve sleep, and avoided the unacceptable side effects of prescription medications. The most commonly used botanical sleep aids were introduced in Europe and the USA (Escourrou et al., 2000; Pearson et al., 2006) . However, Zizyphus jujuba, Fructus jujubae and Arillus Longan are Chinese herbs used in the treatment of insomnia (Table 1) .
St John's wort (Hypericum perforatum) is the most popular and well-studied herbal treatment for psychiatric problems in the West in recent years. H. perforatum has long been used as a remedy for wound healing, mild sedation, and pain relief (Barnes et al., 2001) . Its fl owers, leaves, bark, fruit, seeds, stems, and roots have all been used to treat insomnia and depression. However, two recent large-scale randomized controlled studies reported confl icting results on the effi cacy of St John's wort in treating depression. The use of St John's wort as a hypnotic has not been systematically studied. A cross-over double-blind placebo-controlled study of high-dose hypericum extract in 12 elderly healthy volunteers suggested that St John's wort induced an increase in deep sleep, but had no effect on other sleep parameters. Based on the results of St John's wort in treating depression and the suggestion that it may modulate REM and deep sleep; however, further study on the potential hypnotic properties of St John's wort is necessary (Sharpley et al., 1998) . Hypericin and pseudohypericin, are postulated to be the main active ingredients of St John's wort. The crude extract has signifi cant in vitro receptor affi nity for GABA, benzodiazepines, inositol triphosphate, and monoamine oxidase A and B (Butterweck, 2003; Kubin et al., 2005) . Chronic treatment with hypericum may also downregulate β 1 -adrenoceptors and upregulate post-synaptic 5-HT 1A and 5-HT 2 receptors (Teufel-Mayer and Gleitz, 1997; Tadros et al., 2009) . In general, St John's wort is well tolerated, with minimal side-effects, including sedation, dry mouth, dizziness, gastrointestinal upset, restlessness, and hypersensitivity (Dugoua et al., 2006) . Potential drug interactions with serotonin reuptake inhibitors and monoamine oxidase inhibitors have been reported (Bennett et al., 1998) . It would be interesting to see whether Asian hypericums share similar psychotropic properties with those reported for St John's wort. Today, some people use St. John's wort to treat mild to moderate depression, anxiety and sleep disorders.
Kava Kava (Piper methysticum) is a large shrub cultivated in the South Pacifi c islands. Kava is the term used for both the plant and the beverage made from it. The beverage is prepared from the root of the P. methysticum shrub, also called the pepper plant. Recently, kava kava, in various preparations, has become popular in the United States and Europe, where it is generally sold as an herbal supplement to treat anxiety, stress and sleep disorders, often the underlying causes of insomnia (Wheatley, 2001b; Larzelere and Wiseman, 2002) .
The active constituents are the kavalactones or kavapyrones, including kawain, dihydrokawain, methysticin, and dihydromethysticin; the CNS activity of kava kava is due to this group of resinous compounds (Cheng et al., 1988; Dinh et al., 2001; Xuan et al., 2008) . Research indicates that kava kava acts as a central nervous system depressant, and possesses muscle relaxant and analgesic effects in animals (Abebe, 2002) . In several clinical trials, mainly conducted with a dose of 300 mg kava extract per day, kava has been employed successfully for the treatment of anxiety disorders (Gale and Oakley-Browne, 2004; Geier and Konstantinowicz, 2004) . While the underlying mechanism is not entirely clear, it is possible that kava kava acts indirectly on GABA and benzodiazepine binding sites in the brain (Yuan et al., 2002) . The effectiveness of kava kava as a sleep aid has also been studied. It was found that kava extract increased sleep spindle density with activity comparable to tranquilizers and improved subjective parameters of sleep quality. Kava also decreased sleep latency, duration of wake phase, and sleep stage 1. Several relatively short-term clinical studies provide favorable evidence that kava kava is effective in treating anxiety and insomnia (Wheatley, 2001a; Meolie et al., 2005) . Because of the increasing use of kava preparations, possible side effects are a concern.
Valerian (Valeriana offi cinalis), from the plant family Valerianaceae, has been a popular Western botanical medicine used for its mild sedative and tranquilizing effects since the 17th century. The use of the rhizome and roots of V. offi cinalis as an anxiolytic and sleep aid dates back 1,000 years (Pallesen et al., 2002) . In 1996, valerian was one of the 25 best-selling herbs in the United States (Chung and Lee, 2002; Koetter et al., 2007) . In most countries, it is marketed as an over-the-counter product for this purpose. The U.S. Food and Drug Administration (FDA) rates valerian as a generally recognized as safe (GRAS) herb. Valerian contains valepotriates, valerenic acid, and unidentifi ed aqueous constituents that contribute to the sedative properties of valerian. Valerenic acid is a sesquiterpene compound, which may represent an active compound and is used in standardization. Valerian root also contains 0.3-0.7 percent of a pungent volatile oil that contains bornyl acetate and the sesquiterpene derivatives of valerenic acid (Khom et al., 2007) . Valerian has been shown to have sleep-inducing, anxiolytic, and tranquilizing effects in in vivo animal studies and clinical trials. In clinical studies, valerian extract at bedtime led to improve sleep quality, decrease sleep latency, and reduced the number of night awakenings. From two other clinical studies, valerian before bed also improved insomnia (Koetter et al., 2007; Taibi et al., 2009) . One EEG study reported that a dried extract of valerian, taken three times daily, improved delta sleep and decreased stage 1 sleep with repeated rather than single-dose administration (Balderer and Borbely, 1985) . In general, clinical studies with valerian extract show that it has mild hypnotic effects and that it improves sleep quality. Animal studies suggest that valerian has a similar behavioral effect to that of benzodiazepines. More recent research suggests that GABA and serotonin may contribute to the activity of valerian extracts (Dietz et al., 2005; Benke et al., 2009) .
Passion fl ower (Passifl ora incarnata) consists of the dried fl owering and fruiting top of a perennial climbing vine (Family: Passifl oraceae). Although studies proving its effi cacy are lacking, it is usually used for insomnia (Wheatley, 2005) . Active components of passion fl ower may include indole alkaloids, DOI: 10.4062/biomolther.2011.19.3.274 maltol, ethyl-maltol, and fl avonoids (Wheatley, 2005) . When administered intraperitoneally to rats, passion fl ower extract signifi cantly prolonged sleeping time (Krenn, 2002) . The principal fl avonoid, chrysin, was demonstrated to have benzodiazepine receptor activity (Nassiri-Asl et al., 2007) . The usual daily dose is 4-8 g taken as a tea. Because alkaloid compounds are uterine stimulants, passion fl ower extract is not recommended for pregnant women (Soulimani et al., 1997) .
Semen Zizyphi Spinosae is one of the most common ancient Chinese remedies for the treatment of insomnia. This herb is the dried ripe seed of the Zizyphus jujube (Family: Rhamnaceae). It has been used as an analgesic, tranquilizer and as an anticonvulsant. Animal studies suggest that it protects cerebral ischemic injuries, has hypnotic effects in rats, modulates stress-induced sleep changes in mice, and enhances total sleep time and slow wave sleep in rabbits. It is a common ingredient of traditional herbal formulas used in treating insomnia. Its extract of zizyphi contains pharmacologically active compounds such as fl avones, alkaloids and triterpenes (Lee et al., 1996; Cheng, 2000) . The hypnotic effect of semen zizyphi spinosi was postulated to be due to the anti-cholinergic and anti-histaminergic actions of betulic acid, an active compound of this herb. However, peptide alkaloids from semen zizyphi spinosi increased total sleeping time through modulation of GABAergic systems (Ma et al., 2007) . In vitro analysis suggests an affi nity for 5HT1a, 5HT2, and GABA receptors (Yi et al., 2007) . Side effects consisting of gastrointestinal symptoms, dizziness and skin rash were reported.
Fructus Jujubae is the dried ripe fruit of Zizyphus jujube (Family: Rhamnaceae). The use of this fruit has a long tradition and a traditional herbal formula, 'liquorice, wheat and jujuba soup', which was fi rst recorded during the Han dynasty (Wang et al., 1995) . This has been a common prescription for treating mental problems including neurasthenia, insomnia, and even schizophrenia (Huang et al., 1991) . The active biochemical ingredient of the herbal formula is unknown. Jujube contains stepharine, N-nor-nuciferine, asimilobine, and two kinds of Zizyphus saponin.
Arillus Longan is commonly consumed as the dried fruit of Euphoria longana (Family: Sapindaceae). The pulp of the dried fruit, as well as fresh Longanae Arillus, has been consumed for the treatment of anxiety and insomnia in Asian countries. In a pharmacological study, the extract of Longanae Arillus was proven to have anxiolytic activity (Okuyama et al., 1999) . The methanol extract of Longanae Arillus prolonged sleep time and reduced sleep latency induced by pentobarbital. The extract itself does not induce sleep, but modulates GABAergic systems (Ma et al., 2009) . Phytochemicals were extracted with 70% methanol from peel, pulp, and seed tissues of longan fruit, and the major components were identifi ed as gallic acid, corilagin (ellagitannin), and ellagic acid (Rangkadilok et al., 2005) .
Ginseng may be, at least in part, related to maintaining normal sleep and wakefulness. Of the several species of ginseng, Panax ginseng (Korean or Asian ginseng), Panax quinquefolius (American ginseng), and Panax vietnamensis (Vietnamese ginseng) are reported to have sleep-modulating effects. Constituents of most ginseng species include ginsenosides, polysaccharides, peptides, polyacetylenic alcohols, and fatty acids (Kaku et al., 1975) . Ginseng has an inhibitory effect on the CNS and may modulate neurotransmission. A mixture of the ginsenosides Rb1, Rb2, and Rc from Panax ginseng extracts prolonged the duration of hexobarbital-induced "sleep" in mice (Takagi et al., 1972) . Rhee et al. reported that Panax ginseng extract decreased the amount of wakefulness during a 12-hour light period and increased the amount of slow wave sleep . In addition, red ginseng extract increased total sleep and NREM sleep (Ma et al., 2008; Yang et al., 2010) , and it was reported that Panax ginseng extract normalized the disturbances in sleep-waking states caused by food deprivation in rats . Majonosides R2, a major saponin isolated exclusively from Panax vietnamensis, restored the hypnotic activity of pentobarbital, which was decreased by two models of psychological stress (Nguyen et al., 1996) . In a recent double-blind study investigating the infl uence of ginseng on the quality of life of urban dwellers, a daily dose of 40 mg ginseng extract for 12 weeks signifi cantly improved quality of life, including sleep (Hartley et al., 2004) . There is evidence to suggest that regulation of GABAergic neurotransmission is one mechanism for the CNS-depressant action of ginseng extract and ginsenosides. Ginsenosides have been reported to compete with agonists for binding to GABA A and GABA B receptors (Kimura et al., 1994) . There are few reports of severe side-effects secondary to ginseng, despite the fact that over six million people ingest it regularly in the United States (Kabalak et al., 2004) . The most common reported side effects are nervousness and excitation, but these diminish with continued use or dosage reduction. On the basis of its long-term usage and the relative infrequency of reported signifi cant side effects, it is safe to conclude that ginseng is not associated with serious adverse reactions (Choi et al., 1999; Vazquez and Aguera-Ortiz, 2002) . Because the possibility of hormone-like or hormone-inducing effects cannot be ruled out, some authors suggest limiting treatment to three months. Moreover, some participants reported less sleep and poor quality of sleep following ginseng use.
CONCLUSION
Recently, there has been great interest in alternative or complementary medicine, both locally and internationally. In the CNS, alkaloids and fl avones bind to the benzodiazepine site on the GABA A -receptors resulting in sedation, anxiolytic or anti-convulsant effects. The use of herbs in the treatment of psychiatric problems including insomnia is not exclusive to oriental countries. Therefore, this review covered both western and oriental herbs used in the treatment of insomnia. The difference between the western and oriental use of herbs is that western herbs are more often used singly, while herbs used in oriental countries are usually in combined formulas. Western herbs for the treatment of insomnia have been studied more extensively than oriental herbs, both pre-clinically and clinically. Thus, more basic and clinical studies for oriental herbs are required to demonstrate their effi cacy and safety. The modern scientifi c approach to research, using randomized controlled studies, with standardized dosages and measurements (both subjective and objective) is necessary, and careful monitoring of any adverse effects and potential drug interactions is essential. Some individual TCM herbs, such as Semen zizyphi spinosae, Fructus zizyphi jujubae, and Longanae Arillus appear promising for the treatment of insomnia. Oriental botanical herbs especially, have not yet been fully studied for clinical use.
